Sun et al [39] used a customized 85-gene NGS panel to monitor ctDNA of early-stage CRC patients for 6 months following surgery, and observed decrease in driver mutation in half of the patients after surgery and increase of TP53 and PIK3CA mutations in a patient with liver metastasis. This evidence concerns the gene TP53 and colorectal carcinoma.